Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lyras is a private Danish industrial technology company that develops and sells raslysation, a non-thermal liquid processing platform that uses ultraviolet light as an alternative to conventional pasteurization and microfiltration. The company focuses on resource-efficient processing for liquids used in dairy, juice, industrial fermentation, and blood plasma applications. Its systems are positioned to reduce energy and water consumption while maintaining product quality and food or feed safety. Lyras operates commercially from Denmark with a North American presence in Chicago. While it touches blood plasma processing as an end market, it is primarily an equipment and process technology company rather than a biotech or healthcare company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lyras.